Studies in peripheral blood mononuclear cells (PBMCs) from amnestic MCI and AD patients show differential expression of senescence markers, such as cell cycle blockade (p16 and p53), DNA damage response (γH2AX) and proinflammatory IL-6/-8 mRNA levels [9]. This evidence concerns the gene IL6 and Alzheimer disease.